Abstract
Background
Carbamazepine (CBZ) formed the gold standard drug in trigeminal neuralgia (TN) treatment but faces high therapeutic failure. This defined the need to explore a second line of drug therapy. The study aimed at comparing two alternate drugs i.e. Lamotrigine (LTG) and Pregabalin (PGB), in the management of TN refractory to therapeutic doses of CBZ.
Methods
Twenty-two patients with diagnosis of refractory TN were enrolled and randomly allotted into 2 groups of 11 each. Each group was subjected to a crossover analysis using LTG and PGB together with CBZ, for a period of 6 weeks. Patients maintained a pain diary, the scores of which, along with global evaluation scores, determined the primary outcome. Reevaluation of symptoms after 6 months was done to assess long term efficacy with study drugs.
Results
Both LTG and PGB were effective over CBZ alone (p < 0.05); however, statistically insignificant difference (p > 0.05) was observed between the two groups using Mann–Whitney tests. Unlike LTG, side effects like nausea, insomnia and concentration loss were minimal with PGB thus exhibiting greater patient compliance. Secondary analysis showed complete relief in 4 patients on PGB (mean dose 240.68 mg/day) while 6 had partial relief. Three patients on LTG (mean dose 310.90 mg/day) reported relapse of acute symptoms and required peripheral alcohol blocks.
Conclusion
Pregabalin has potential anti-neuralgia properties comparable to LTG. However, the level of patient’s tolerance seen with PGB exceeds that with LTG. 6 months follow-up records suggest that PGB together with CBZ offers a more reliable pain control than with LTG.
Similar content being viewed by others
References
Zakrzewska JM, Patsalos PN (1992) Drugs used in the management of trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radio Endod 74:439–450
Katusic S, Beard CM, Bergstralh E, Kurland LT (1990) Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol 27:89–95
Taha JM, Tew JM Jr (1996) Comparisons of surgical treatment for trigeminal neuralgia: reevaluation of radiofrequency rhizotomy. Neurosurgery 38:865–887
Taylor JC, Brauer S, Espir ML (1981) Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrads Med J 57:16–18
Bertilsson L (1978) Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet 3:128–143
Spina E, Pisani F, Perucca E (1996) Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31:198–214
Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J et al (1997) The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153–160
McCleane G (1998) Lamotrigine can remove the pain associated with painful diabetic neuropathy. Eur J Neurol 5:167–173
Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A (2001) Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 57:505–509
Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H et al (2003) Pregabalin for the treatment of post-herpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274–1283
Frampton JE, Foster RH (2005) Pregabalin in the management of post-herpetic neuralgia. Drugs 65:111–118
Rosenstock J, Arezzo JC, LaMoreaux L, Murphy TK, Pauer L, Sharma U (2007) Efficacy and safety of pregabalin as treatment of painful diabetic peripheral neuropathy (DPN): a 13-week randomized controlled trial and 6-month safety extension. Euro J Pain 11:S128–S129
Vranken JH, Dijkgraaf MGW, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M (2008) Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 136:150–157
Betts T, Goodwin G, Withers RM, Yuen AWC (1991) Human safety of lamotrigine. Epilepsia 32(Suppl (2)):S17–S21
Keck PE, McElroy SN (2002) Clinical pharmacodynamics and pharmacokinetics of anti-maniac and mood stabilizing medications. J Clin Psychiatry 63(Suppl 4):S3–S11
Guay D (2005) Pregabalin in neuropathic pain: a more “pharmaceutically elegant” gabapentin? Am J Geriatr Pharmacother 3:274–287
Peel MC, Finlayson BL, McMahon TA (2007) Updated world map of the Köppen–Geiger climate classification. Hydrol Earth Syst Sci 11:1633–1644
Loeser D (2001) Cranial neuralgia. In: Loeser JD, Bonica JJ (eds) Bonica’s management of pain, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 855–861
Siddiqui M, Siddiqui S, Ranasinghe JS, Furgang F (2003) Pain management: trigeminal neuralgia. Hosp Phys 39:64–70
Chole R, Patil R, Shirish D, Bhowate R (2007) Drug treatment of trigeminal neuralgia: a systematic review of the literature. J Oral Maxillofac Surg 65:40–45
Altman D (1991) Practical statistics for medical research. Chapman and Hall, London, pp 467–471
Barker FG II, Jannetta PJ, Bisonette DJ, Larkins MV, Jho HD (1996) The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 334:1077–1083
Melzack R, Terrence C, Fromm G, Amsel R (1986) Trigeminal neuralgia and atypical facial pain: use of the McGill pain questionnaire for discrimination and diagnosis. Pain 27:297–302
Sato J, Saitoh T, Notani K, Fukuda H, Kaneyama K, Segami N (2004) Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:18–22
Cheshire WP (2002) Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain 3:137–142
Zakrzewska JM, Chaudhry Z, Nurmikko TuroJ, Patton DW, Lynette EM (1997) Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73:223–230
Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z (2008) Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28:174–181
Silver M, Blum D, Grainger J, Hammer AnneE, Quessy S (2007) Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage 34:446–454
Braga AJ, Chidley K (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62:524–527
Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P et al (2004) Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 109:26–35
Schapel GJ, Dollman W, Beran RG, Dunagan FM (1991) No effect of lamotrigine on carbamazepine and carbamazepine-epoxide concentrations. Epilepsia 32(Suppl (1):S58
Freynhagen R, Strojek K, Griesing T, Whalen E, Mn Balkenohl (2005) Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115:254–263
McLeod N, Patton DW (2007) Peripheral alcohol injections in the management of trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:12–17
Fardy MJ, Patton DWP (1994) Complications associated with peripheral alcohol injections in the management of trigeminal neuralgia. Br J Oral Maxillofac Surg 32:387–391
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rustagi, A., Roychoudhury, A., Bhutia, O. et al. Lamotrigine Versus Pregabalin in the Management of Refractory Trigeminal Neuralgia: A Randomized Open Label Crossover Trial. J. Maxillofac. Oral Surg. 13, 409–418 (2014). https://doi.org/10.1007/s12663-013-0513-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-013-0513-8